FStar.jpg
F-star Therapeutics Shows Differentiation of FS222 in 2021 AACR Poster
10 avr. 2021 09h22 HE | F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...
CLS-Logo-1.jpg
CLS and Advanced Medical Systems Form Joint Venture Cooperation, Introducing the Innovative TRANBERG® Thermal Therapy System and imILT® in the Asia-Pacific Region
24 août 2020 03h00 HE | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of innovative image-guided laser ablation technology for minimally invasive soft tissue and...
CLS-Logo-1.jpg
CLS Conducts In-Vivo Laser Ablation Studies for Neuro and Prostate using TRANBERG Thermal Therapy System with Thermoguide
22 mai 2020 04h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, May 22, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it is conducting new in-vivo precision laser ablation treatment...
CLS-Logo-1.jpg
CLS Granted New U.S. Patent Covering Unique, Non-Cooled, Diffuser-type Laser Ablation Applicator
29 avr. 2020 07h00 HE | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and LUND, Sweden, April 29, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it was granted a new U.S. Patent valid until 2036 covering its...